Top Markets
Coin of the day
Beta Bionics, Inc. Beta Bionics, Inc.

Beta Bionics, Inc.

BBNX
Rang in aandelen #10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Aandeelprijs
$19.81
Laatst gesynchroniseerd: 2026-08-28
Marktkapitalisatie
$891.32M
Verandering (1 dag)
1.39%
Verandering (1 jaar)
5.16%
Land
US
Handel Beta Bionics, Inc. (BBNX)

Categorie

Aandelsplitsingen voor Beta Bionics, Inc. (BBNX)
Het aandeel Beta Bionics, Inc. (symbool: BBNX) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 30, 2026.
Eén aandeel BBNX dat vóór Aug 30, 2026 werd gekocht, staat nu gelijk aan 0 aandelen BBNX.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE